Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH.
Steffen D KriechbaumLillith ScherwitzChristoph B WiedenrothFelix RudolphJan-Sebastian WolterMoritz HaasUlrich Fischer-RasokatAndreas RolfChristian W HammEckhard MayerStefan GuthStavros V KonstantinidesMareike LankeitChristoph LiebetrauPublished in: ERJ open research (2020)
MR-proANP and copeptin levels are affected in CTEPH and decrease after therapy. MR-proANP identifies a severe disease status and optimal therapy response.